EXAGEN INC. (XGN) News

EXAGEN INC. (XGN): $3.00

-0.10 (-3.23%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add XGN to Watchlist
Sign Up

Filter XGN News Items

XGN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

XGN News Highlights

  • For XGN, its 30 day story count is now at 6.
  • Over the past 16 days, the trend for XGN's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • The most mentioned tickers in articles about XGN are LI, UL and PR.

Latest XGN News From Around the Web

Below are the latest news stories about EXAGEN INC that investors may wish to consider to help them evaluate XGN as an investment opportunity.

Exagen (NASDAQ:XGN) shareholders are up 20% this past week, but still in the red over the last three years

Exagen Inc. ( NASDAQ:XGN ) shareholders will doubtless be very grateful to see the share price up 43% in the last...

Yahoo | May 17, 2023

Q1 2023 Exagen Inc Earnings Call

Q1 2023 Exagen Inc Earnings Call

Yahoo | May 16, 2023

Exagen GAAP EPS of -$0.44 beats by $0.12, revenue of $11.2M beats by $1.8M

  • Exagen press release (NASDAQ:XGN): Q1 GAAP EPS of -$0.44 beats by $0.12.
  • Revenue of $11.2M (+7.7% Y/Y) beats by $1.8M.
  • We are providing revenue guidance for the second quarter of 2023 in the range of $10.7 million to $11.2 million vs $10.53M consensus

...

Seeking Alpha | May 15, 2023

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates

Exagen Inc. (XGN) delivered earnings and revenue surprises of 15.38% and 18.21%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 15, 2023

Exagen Inc. Reports First Quarter 2023 Results

Record Physician Demand for AVISE® CTDSAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN)("Exagen"), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2023. First Quarter Highlights: Delivered a record 37,312 AVISE® CTD tests in the first quarter, a 21% increase over the first quarter of 2022 and a 10% increase over the fourth quarter of 2022.Recognized total revenue of $11.2 million for the first quarter, an 8%

Yahoo | May 15, 2023

Exagen Announces Campaign for Lupus Awareness Month

SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign focusing on providers, patients and partnership activities that enhance the impactful work being done to help those suffering from Systemic Lupus Erythematosus (SLE). Lupus Awareness Month occurs every May and is an opportunity for lupus-focused organizations to take intentional steps in creat

Yahoo | May 1, 2023

Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023

SAN DIEGO, April 24, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2023, after the market close on Monday, May 15, 2023. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Company’s results at 4:30 PM ET (1:30 PM PT). Interested parties may access the conference call by dialing (201)

Yahoo | April 24, 2023

Exagen Inc. (NASDAQ:XGN) Q4 2022 Earnings Call Transcript

Exagen Inc. (NASDAQ:XGN) Q4 2022 Earnings Call Transcript March 20, 2023 Operator: Greetings, and welcome to the Exagen Inc. Fourth Quarter Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure […]

Yahoo | March 24, 2023

Exagen Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

Exagen ( NASDAQ:XGN ) Full Year 2022 Results Key Financial Results Revenue: US$45.6m (down 5.7% from FY 2021). Net...

Yahoo | March 22, 2023

Q4 2022 Exagen Inc Earnings Call

Q4 2022 Exagen Inc Earnings Call

Yahoo | March 21, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7654 seconds.